In conditions of insulin resistance, such as central obesity, type 2 diabetes mellitus with obesity, and essential arterial hypertension, a deep reduction of platelet sensitivity to the antiaggregating effects of insulin has been reported [34, 137–139]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.